Interchange Capital Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Interchange Capital Partners's ABBV Position: Q2 2026 in Review
Interchange Capital Partners increased its AbbVie (ABBV) stake by 7.8% in Q2 2026, buying an estimated $253K and bringing the position to 16,195 shares worth $4.08M. The position accounts for 0.77% of the portfolio, ranked #25.
Interchange Capital Partners first reported a position in ABBV in Q4 2020 and has held it in 18 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Interchange Capital Partners held 16,195 shares of AbbVie worth $4.08M as of Q2 2026.
- Interchange Capital Partners bought 1,176 AbbVie shares in Q2 2026, an estimated $253K.
- AbbVie made up 0.77% of Interchange Capital Partners's portfolio in Q2 2026, its #25 holding.
- Interchange Capital Partners first reported a position in AbbVie in Q4 2020 and has held it in 18 quarters since.
- 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Interchange Capital Partners's 13F filing for Q2 2026, filed 20 Jul 2026.